“We in India greatly value the role we are able to play in the fight against leprosy.
India has around 70% of the world’s leprosy cases and we look forward to the day
when leprosy is eliminated and patients suffering from leprosy are integrated into
mainstream society,” said Ranjit Shahani, Vice Chairman & Managing Director,
Novartis India Limited.